Search research articles
Contact Us
Filters
Showing results (231-240 of 305) with videos related to
Page
of 31
Sort By:
Talanta
|
January 1, 1989
Some industrial developments and applications of multidimensional techniques
W B Crummett, H J Cortes, T G Fawcett, et al.
Leukemia
|
July 21, 2006
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
E Jabbour, H Kantarjian, D Jones, et al.
Journal of Surgical Oncology
|
July 12, 2011
Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device
Manuel E Ruidiaz, Maria J Cortes-Mateos, Sergio Sandoval, et al.
International Journal of Oral and Maxillofacial Surgery
|
February 4, 2016
Implant survival and complications in cases of inferior alveolar nerve lateralization and atrophied mandibles with 5-year follow-up
N Martínez-Rodríguez, C Barona-Dorado, J Cortes-Breton Brinkmann, et al.
Leukemia
|
November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results
P D le Coutre, F J Giles, A Hochhaus, et al.
Frontiers in Reproductive Health
|
September 18, 2025
Implementation strategies to support pre-exposure prophylaxis for HIV prevention care for cisgender women in federally-funded family planning clinics in Atlanta, Georgia
K M Anderson, L V Bonadonna, E J Cortes, et al.
ESMO Open
|
December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective
C Sessa, J Cortes, P Conte, et al.
Leukemia
|
June 6, 2012
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission
Y Boumber, H Kantarjian, J Jorgensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
J-C Soria, J Cortes, C Massard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine
H M Kantarjian, S O'Brien, T L Smith, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 305) with videos related to
Sort By:
Page
of 31
Talanta
|
January 1, 1989
Some industrial developments and applications of multidimensional techniques
W B Crummett, H J Cortes, T G Fawcett, et al.
Leukemia
|
July 21, 2006
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
E Jabbour, H Kantarjian, D Jones, et al.
Journal of Surgical Oncology
|
July 12, 2011
Quantitative comparison of surgical margin histology following excision with traditional electrosurgery and a low-thermal-injury dissection device
Manuel E Ruidiaz, Maria J Cortes-Mateos, Sergio Sandoval, et al.
International Journal of Oral and Maxillofacial Surgery
|
February 4, 2016
Implant survival and complications in cases of inferior alveolar nerve lateralization and atrophied mandibles with 5-year follow-up
N Martínez-Rodríguez, C Barona-Dorado, J Cortes-Breton Brinkmann, et al.
Leukemia
|
November 15, 2011
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results
P D le Coutre, F J Giles, A Hochhaus, et al.
Frontiers in Reproductive Health
|
September 18, 2025
Implementation strategies to support pre-exposure prophylaxis for HIV prevention care for cisgender women in federally-funded family planning clinics in Atlanta, Georgia
K M Anderson, L V Bonadonna, E J Cortes, et al.
ESMO Open
|
December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective
C Sessa, J Cortes, P Conte, et al.
Leukemia
|
June 6, 2012
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission
Y Boumber, H Kantarjian, J Jorgensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
J-C Soria, J Cortes, C Massard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine
H M Kantarjian, S O'Brien, T L Smith, et al.
Page
of 31